reqspace
Start free trial →
2
2332 Laboratoire Glaxo Smith Kline S.A.S.

Site Transformation Lead(m/f/d - temp position for 12 months)

Heidelberg - Officeonsitesenior$93K – $155K

Posted today · via Workday

See if I'm a fit →Tailor my resume for this role →Apply on Workday ↗

About this role

Job Purpose R&D Engineering Services (RDES) provides Facilities Management, Engineering and Capital Project services tailored to the needs of R&D across its technical sites within GSC’s Engineering and EHS organization. This role will partner with R&D leadership, RDES operations management, and key Service Delivery Partners to drive transformation initiatives at the GSK Research and Development (R&D) site in Heidelberg, Germany. The site is located on the campus of the European Molecular Biology Laboratory (EMBL) and offers a highly interdisciplinary scientific environment that enables technological innovation and helps translate research discoveries into meaningful scientific and business value for GSK.…

Read the full description on 2332 Laboratoire Glaxo Smith Kline S.A.S.'s site →

What we'd score you on

reqspace match rubric

Five dimensions, recruiter-grade. Upload your resume and we'll generate a written explanation of where you fit and where the gaps are.

1

Skills match

For this role: r, teams

2

Level fit

This role is senior-level. We check your trajectory against it.

3

Domain experience

Your work in the role's domain matters more than your years total. We weight recent and direct experience.

4

Recency

A skill you used last quarter weighs more than one from five years ago. We grade on recency, not lifetime.

5

Location fit

This role is based in Heidelberg - Office. We weight your proximity and willingness to relocate.

Score yourself on this role.
Free · no card · written explanation included
See if I'm a fit →

Skills in this role

Pulled from the job description. These are the keywords we'll weight when scoring your fit.

rteams

More at 2332 Laboratoire Glaxo Smith Kline S.A.S.

See all open jobs at 2332 Laboratoire Glaxo Smith Kline S.A.S. →